Balloon Efficiency
with Single Point Versatility

Apama Medical is committed to improving the treatment of atrial
fibrillation (AF) by developing novel catheter ablation technology.

Clinical Problem

The Growing Problem of AF

What is AF? AF is an abnormal heart rhythm characterized by rapid and irregular beating.

Leerink Swann, Future of AF 091313
CDC Atrial Fibrillation Fact Sheet
Camm AJ et. al. Guidelines for the management of atrial fibrillation. European Heart Journal (2010) 31, 2369–2429
Leerink Swann, Future of AF 091313

SERIOUS RISKS + SIGNIFICANT COSTS

Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor of stroke: the Farmingham Study. Stroke. 1991;22;983-8.)
Camm AJ et. al. Guidelines for the management of atrial fibrillation. European Heart Journal (2010) 31, 2369–2429
Leerink Swann, Future of AF 091313
Coyne KS, et al. Assessing the direct costs of treating nonvalvuar atrial fibrillation in the United States. Value in Health 2006;9(5):348-356

Gaps in Current Treatment

Minimally invasive catheter ablation is a growing treatment option for AF,
however limitations with existing technology remain.

Our Solution

Apama Medical is developing a novel ablation catheter technology that combines the best elements of existing ablation technology, while incorporating additional unique features to address gaps in current technology.

Significantly reduces procedure time due to multipoint, single-shot design and optimizes lesion placement via real-time visualization

Provides solutions for patients with various AF types due to its ability to create customizable lesion patterns

Incorporated irrigation reduces risk of clot formation